Paratek Pharmaceuticals (PRTK) Acknowledges Receipt of NexPoint Letter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. GMAB
4. ACCV
5. QQQ
6. SPCX
7. AZN
8. APO
9. FICO
10. IIB:IN

Go back to Paratek Pharmaceuticals (PRTK) Acknowledges Receipt of NexPoint Letter

Paratek Pharmaceuticals Acknowledges Receipt of NexPoint Letter

June 27, 2023 12:01 PM EDT

BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Paratek) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for life-threatening diseases and other public health threats, today acknowledged receipt of a letter from NexPoint Asset Management, L.P., together with its affiliates (collectively, "NexPoint").

Paratek appreciates receiving constructive feedback from its stockholders and as such, has actively engaged with NexPoint over the past several months. However, Parateks board of directors respectfully disagrees with NexPoints characterizations contained in its letter.

Paratek looks forward to providing... More